NEW YORK (Reuters Health) – Continuous glucose monitoring (CGM) improved diabetes control and reduced glucose variability and was well liked in two studies of patients with type 1 diabetes using multiple daily insulin injections.
Top Stories On Health
When Gina Brown was diagnosed with HIV in 1994, she considered it a death sentence, but nearly 23 years later, she’s living a full life in New Orleans, thanks largely to the federally funded Ryan White HIV/AIDS Program.
Aetna and Humana would consider all available options for their proposed US$34 billion merger, the two U.S. health insurers said on Tuesday, a day after a court ruled against the deal due to fears it would lower competition.
A bird flu outbreak in north Germany this week was of a new subtype called H5N5, the first time the strain has been confirmed on a German farm, the country's national animal disease center said on Tuesday.
The U.S. Food and Drug Administration (FDA) has granted priority review designation of Roche's rheumatoid arthritis medication Actemra for giant cell arteritis (GCA), the Swiss drugmaker said on Tuesday.
Some prominent U.S. fund managers are betting that former President Barack Obama's signature healthcare law will not undergo the widespread changes that President Donald Trump promised on the campaign trail.